Kirkland Signature Coenzyme Q10 300 mg
Kirkland Signature Coenzyme Q10 300 mg, NPN 80138820: natural health product licensed in Canada. Medicinal ingredients: 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Rhodobacter sphaeroides - Whole | 300 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Glycérine, Huile de son de riz, d-alpha tocophérol, Pectine, Eau, Sorbitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain and/or support cardiovascular health. Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic/preventative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Ask/Consult a physician before/prior to use if you are pregnant or breastfeeding. Ask/Consult a physician before/prior to use if you are taking blood pressure medication. Ask/Consult a physician before/prior to use if you are taking blood thinners. Migraine prophylaxis/prevention: Ask/Consult a physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
Product record
- Other names
- Coenzyme Q10 300 mg, Coenzyme Q10 300 mg Extra Strength, Extra Strength Coenzyme Q10 300 mg, Kirkland Signature Coenzyme Q10 300 mg Extra Strength, Kirkland Signature Extra Strength Coenzyme Q10 300 mg
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80138820
- Status
- Active licence
- Licence date
- 27 February 2025
- Revision date
- Not provided
- Form
- Capsule, libération retardée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80138820
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Kirkland Signature Coenzyme Q10 300 mg (WN Pharmaceuticals Ltd): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80138820-kirkland-signature-coenzyme-q10-300-mg, updated 27 February 2025.